Powered by

BioSyent underperforms 86% of the market March 06, 2017 17:00 EST

Mar 6, 2017 - News Bites Canadian Markets


BioSyent Inc. (TSXV:RX), Canada's 3rd largest Drug manufacturers company by market cap, has dropped 29.0c (3.8%) from its last trading session of March 03 to close at CAD7.30. Compared with the S&P/TSX 60 Index which rose 2.9 points (0.3%) in the day, the relative price change was -4.1%. The volume was 0.4 times the average daily trading volume of 20,062 shares. In the Canadian market of 1,992 stocks and 84 units traded today, the stock has a 10-week relative pr

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox